Jonathan P Mow Insider Trading $PHAS PhaseBio Pharmaceuticals Inc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jonathan P Mow.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jonathan P Mow. Jonathan P Mow is Chief Executive Officer in PhaseBio Pharmaceuticals Inc ($PHAS).
Jonathan P Mow in PhaseBio Pharmaceuticals Inc
Trading Symbol: PHASIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jonathan P Mow: Chief Executive Officer
Holdings: 122,886 shares
Latest Transaction: Feb 09 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Jonathan P Mow in PhaseBio Pharmaceuticals Inc
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 09 2021 | PHAS | PhaseBio Pharmaceu ... | Mow Jonathan P | Chief Executive Off ... | Option Exercise | A | 4.31 | 234,000 | 1,008,540 | 234,000 | |
Nov 23 2020 | PHAS | PhaseBio Pharmaceu ... | Mow Jonathan P | Chief Executive Off ... | Grant | A | 3.00 | 3,643 | 10,929 | 122,886 | 119.2 K to 122.9 K (+3.06 %) |
Aug 24 2020 | PHAS | PhaseBio Pharmaceu ... | Mow Jonathan P | Chief Executive Off ... | Option Exercise | M | 1.24 | 10,000 | 12,400 | 148,767 | |
Aug 24 2020 | PHAS | PhaseBio Pharmaceu ... | Mow Jonathan P | Chief Executive Off ... | Buy | M | 1.24 | 10,000 | 12,400 | 119,243 | 109.2 K to 119.2 K (+9.15 %) |
Feb 14 2020 | PHAS | PhaseBio Pharmaceu ... | Mow Jonathan P | Chief Executive Off ... | Option Exercise | A | 5.19 | 290,000 | 1,505,100 | 290,000 | |
Sep 10 2019 | PHAS | PhaseBio Pharmaceu ... | Mow Jonathan P | Chief Executive Off ... | Option Exercise | M | 1.24 | 19,000 | 23,560 | 158,767 | |
Sep 10 2019 | PHAS | PhaseBio Pharmaceu ... | Mow Jonathan P | Chief Executive Off ... | Buy | M | 1.24 | 19,000 | 23,560 | 109,243 | 90.2 K to 109.2 K (+21.05 %) |
May 21 2019 | PHAS | PhaseBio Pharmaceu ... | Mow Jonathan P | Chief Executive Off ... | Option Exercise | M | 1.24 | 19,131 | 23,722 | 0 | |
May 21 2019 | PHAS | PhaseBio Pharmaceu ... | Mow Jonathan P | Chief Executive Off ... | Option Exercise | M | 2.27 | 19,913 | 45,203 | 0 | |
May 21 2019 | PHAS | PhaseBio Pharmaceu ... | Mow Jonathan P | Chief Executive Off ... | Buy | M | 1.24 | 19,131 | 23,722 | 90,243 | 71.1 K to 90.2 K (+26.90 %) |
May 21 2019 | PHAS | PhaseBio Pharmaceu ... | Mow Jonathan P | Chief Executive Off ... | Buy | M | 2.27 | 19,913 | 45,203 | 71,112 | 51.2 K to 71.1 K (+38.89 %) |
Mar 01 2019 | PHAS | PhaseBio Pharmaceu ... | Mow Jonathan P | Chief Executive Off ... | Option Exercise | A | 3.15 | 263,000 | 828,450 | 263,000 | |
Mar 01 2019 | PHAS | PhaseBio Pharmaceu ... | Mow Jonathan P | Chief Executive Off ... | Option Exercise | A | 3.15 | 263,000 | 828,450 | 263,000 | |
Dec 17 2018 | PHAS | PhaseBio Pharmaceu ... | Mow Jonathan P | Chief Executive Off ... | Buy | P | 3.69 | 1,000 | 3,690 | 51,199 | 50.2 K to 51.2 K (+1.99 %) |
Dec 11 2018 | PHAS | PhaseBio Pharmaceu ... | Mow Jonathan P | Chief Executive Off ... | Buy | P | 3.85 | 800 | 3,080 | 51,699 | 50.9 K to 51.7 K (+1.57 %) |
Dec 11 2018 | PHAS | PhaseBio Pharmaceu ... | Mow Jonathan P | Chief Executive Off ... | Buy | P | 3.88 | 2,200 | 8,536 | 50,899 | 48.7 K to 50.9 K (+4.52 %) |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Mow Jonathan P | Chief Executive Off ... | Option Exercise | C | 0.00 | 3,505 | 0 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Mow Jonathan P | Chief Executive Off ... | Option Exercise | C | 0.00 | 310 | 0 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Mow Jonathan P | Chief Executive Off ... | Option Exercise | M | 0.00 | 310 | 0 | 310 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Mow Jonathan P | Chief Executive Off ... | Option Exercise | M | 0.12 | 310 | 37 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Mow Jonathan P | Chief Executive Off ... | Buy | C | 0.00 | 3,505 | 0 | 48,699 | 45.2 K to 48.7 K (+7.76 %) |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Mow Jonathan P | Chief Executive Off ... | Buy | C | 0.00 | 310 | 0 | 310 | 0 to 310 |
Oct 17 2018 | PHAS | PhaseBio Pharmaceu ... | Mow Jonathan P | Chief Executive Off ... | Option Exercise | A | 5.00 | 220,000 | 1,100,000 | 220,000 | |
Oct 17 2018 | PHAS | PhaseBio Pharmaceu ... | Mow Jonathan P | Chief Executive Off ... | Option Exercise | A | 5.00 | 220,000 | 1,100,000 | 220,000 |
Page: 1